American-Iranian investor Amir Heshmatpour made his fortune in US biotech companies. He’s now in Israel with NeOnc, developer of a nasally administered brain cancer drug. Healthcare

At 64, in the midst of giving evidence in the Netanyahu corruption trial, former Walla! CEO Ilan Yeshua cofounded Seraphic Security, acquired this week by Crowdstrike. Mergers & acquisitions

INSS Senior Researcher Prof. Kobi Michael tells “Globes” about potential scenarios in Iran and says Israel will only intervene if asked to do so by the US. Politics

Prof. Michael Hayden left Teva taking two products that it had begun developing. One became an almost $3.5 billion exit last September. Healthcare

Nvidia SVP networking Gilad Shainer tells “Globes” that it would not be possible for the company to power the new AI models without the communication chips developed in Israel. IT

From tax revenues to the shekel to consumption to real estate, the wave of high-value technology company sales has implications that go beyond the sector. Economy

Amnon Shashua tells “Globes” about the huge potential created by Mobileye’s acquisition of Mentee Robotics. Mergers & acquisitions

The influx of foreign residents to Jerusalem’s central neighborhoods is pushing up prices throughout the city. "Globes" investigates. Real estate

Hasan Abasi talks to “Globes” about his startup HAAT, which introduced a food delivery app to Israel’s Arab towns, and is now launching in Tel Aviv-Yafo. Start ups

Insight Partners managing director Teddie Wardi tells “Globes” about Armis’s exit and the obstacles Israeli startups must surmount to become an international corporation. Mergers & acquisitions

“Globes” looks at prices in new residential projects along Israel’s Mediterranean coast from Nahariya to Ashkelon. Real estate

Prof. Itzhak Fried tells "Globes" about the new research center he heads at Reichman University to explore the interface between the human brain and AI as well as his research on sleep and memory. Healthcare